Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Ora H. Pescovitz"'
Publikováno v:
Clinical Chemistry. 58:667-671
If you look up the definition of leader or leadership in several dictionaries, you will find a similar overall description of someone who leads, commands, or moves a group toward a goal. The newer, softer definitions include terms such as guide , inf
Autor:
Amy D. Shapiro, Suzanne L. Bowyer, Debra Wagner, Michael D. Tarantino, Ora H. Pescovitz, Ellen L. Pratt
Publikováno v:
American Journal of Hematology. 79:175-179
The prevalence and significance of autoantibodies found at the time of diagnosis of childhood ITP were studied to correlate their presence with risk for development of chronic ITP. Children presenting with acute or chronic ITP to The James Whitcomb R
Autor:
Todd D. Nebesio, Ora H. Pescovitz
Publikováno v:
The Endocrinologist. 15:44-48
Publikováno v:
The Journal of Pediatrics. 144:643-647
To investigate the definitive diagnosis and underlying causes of congenital hypothyroidism (CH) in eligible children through the use of a standardized protocol.Childrenor =3 years of age with CH without an identified permanent cause underwent a diagn
Autor:
Stephen D. Rubin, Paul V. Plourde, Ora H. Pescovitz, Hann Chang Jou, Erica A. Eugster, Edward O. Reiter
Publikováno v:
The Journal of Pediatrics. 143:60-66
Objective We undertook a 1-year multicenter trial of tamoxifen treatment for precocious puberty in girls with McCune-Albright syndrome (MAS). Study design Girls ≤10 years with classic or atypical MAS were recruited. Pretreatment history was collect
Publikováno v:
Endocrine. 21:289-296
Growth failure in children with high growth hormone (GH) levels, low insulin-like growth factor 1 (IGF-1) levels, and accelerated linear growth in response to exogenous GH is presumed to result from biologically inactive GH. A molecular diagnosis has
Publikováno v:
The Journal of Pediatrics. 141:99-103
Objective: To characterize the development of hypothyroidism in pediatric patients who receive a fixed dose of radioactive iodine (RAI). Study design: Medical records of children treated with fixed-dose RAI for Graves'disease between 1993 and 2001 we
Autor:
Ora H. Pescovitz
Publikováno v:
Pediatric Research. 51:782-786
Society for Pediatric Research Presidential Address 2001: Pediatric Research in the Era of Genomics
Autor:
Ora H. Pescovitz
Publikováno v:
APMIS. 109:S559-S562
Autor:
B. Hanson, Ora H. Pescovitz, Paul Saenger, Campbell Howard, Frederick T. Murray, Edward O. Reiter, Louis S. O'Dea, J Brentzel, Hal Landy, Barry B. Bercu
Publikováno v:
Endocrine. 15:051-056
Saizen (recombinant growth hormone [GH]), 0.2 mg/(kg x wk), was given in an open-label fashion for an average of 51 mo to 27 children with presumed idiopathic GH deficiency who had withdrawn from a trial of Geref (recombinant GH-releasing hormone [GH